Association of HER2 and ErbB3 molecular alterations with afatinib sensitivity in platinum-refractory metastatic urothelial carcinoma (UC) in a phase II trial.
Genitourinary Cancer
Meeting:
2015 Genitourinary Cancers Symposium
Session Type and Session Title:
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Abstract Number:
312
Poster Board Number:
General Poster Session B (Board #E23)
Citation:
J Clin Oncol 33, 2015 (suppl 7; abstr 312)
Author(s):
Noura Choudhury, Alexa Campanile, James Lloyd Wade, Tatjana Antic, Walter Michael Stadler, Yusuke Nakamura, Peter H. O'Donnell; The University of Chicago, Chicago, IL; Cancer Care Center of Decatur, Decatur, IL; The University of Chicago Medicine and Biological Sciences, Chicago, IL
asco2015
（↓文字数の関係上、一部省略）
Association of HER2 and ErbB3 molecular alterations with afatinib sensitivity in platinum-refractory metastatic urothelial carcinoma (UC) in a phase II trial.
Genitourinary Cancer
Meeting:
2015 Genitourinary Cancers Symposium
Session Type and Session Title:
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Abstract Number:
312
Poster Board Number:
General Poster Session B (Board #E23)
Citation:
J Clin Oncol 33, 2015 (suppl 7; abstr 312)
Author(s):
Noura Choudhury, Alexa Campanile, James Lloyd Wade, Tatjana Antic, Walter Michael Stadler, Yusuke Nakamura, Peter H. O'Donnell; The University of Chicago, Chicago, IL; Cancer Care Center of Decatur, Decatur, IL; The University of Chicago Medicine and Biological Sciences, Chicago, IL
Abstract Disclosures